Prosecution Insights
Last updated: October 04, 2026

Osaka Soda Co. Ltd.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Osaka Soda Co. Ltd. is currently managing 4 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 3 distinct examiners and 2 distinct art units. This distribution shows a moderate level of concentration, where certain examiners have a larger influence over the portfolio's progress than others. The focus within the Chemistry & Materials sector suggests a cohesive technical strategy for the company's current filings.

The busiest examiner for this portfolio is KOROTCHKINA, LIOUBOV G, who handles 2 pending office actions. This means that half of the 4 pending office actions are under the review of a single individual. The remaining actions are split between the other 2 distinct examiners. This concentration under KOROTCHKINA, LIOUBOV G allows the applicant to focus their primary prosecution efforts on a single set of examiner preferences while still managing the other distinct examiners across the 2 distinct art units.

For the legal team, the 2 pending office actions assigned to KOROTCHKINA, LIOUBOV G represent a critical path for the portfolio. Success with this examiner could significantly impact the overall health of the company's pending applications in the Chemistry & Materials field. Meanwhile, the presence of 2 distinct art units requires a strategy that is flexible enough to meet the requirements of different technical departments while maintaining a unified approach to the 4 pending office actions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (75%)
§102 only1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KOROTCHKINA, LIOUBOV G 2 29.5% +67.7%
CRUM, VIVIAN FLORENCE 1 100.0% +0.0%
ROELOFSE, CHRISTIAAN 1 64.0% +38.4%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18683737 AQUEOUS CARBON NANOTUBE DISPERSION CRUM, VIVIAN FLORENCE —

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17642626 LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE RIBOSIDE, AND LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE KOROTCHKINA, LIOUBOV G 28d
18782744 LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE RIBOSIDE, AND LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE KOROTCHKINA, LIOUBOV G —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17642626 LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE RIBOSIDE, AND LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE KOROTCHKINA, LIOUBOV G 28d
18782744 LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE RIBOSIDE, AND LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE KOROTCHKINA, LIOUBOV G —
17912769 ACRYLIC COPOYMER, ACRYLIC COPOYMER-CONTAINING COMPOSITION AND CROSSLINKED PRODUCT OF SAME ROELOFSE, CHRISTIAAN —

Top Art Units

Art UnitApps
1762 1
1653 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18782744 LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE RIBOSIDE, AND LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE KOROTCHKINA, LIOUBOV G — §102 Non-Final OA — Pending Jul 24, 2024
18683737 AQUEOUS CARBON NANOTUBE DISPERSION CRUM, VIVIAN FLORENCE — §103 Non-Final OA — Pending Feb 14, 2024
17912769 ACRYLIC COPOYMER, ACRYLIC COPOYMER-CONTAINING COMPOSITION AND CROSSLINKED PRODUCT OF SAME ROELOFSE, CHRISTIAAN 1762 §103 Non-Final OA — Pending Nov 01, 2022
17642626 LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE RIBOSIDE, AND LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE KOROTCHKINA, LIOUBOV G 1653 §103 Final Rejection 28d Pending Mar 11, 2022

Managing Osaka Soda Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month